Market Tracker

12/02 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

4.70
Delayed Data
As of Dec 02
 +0.35 / +8.05%
Today’s Change
3.20
Today|||52-Week Range
29.86
-80.55%
Year-to-Date

Today’s Trading

Previous close4.35
Today’s open4.35
Day’s range4.25 - 4.80
Volume1,487,495
Average volume (3 months)1,862,664
Market cap$181.1M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+1.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book0.97

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.10-1.09%
AKAOAchaogen Inc-0.26-4.42%
ITEKInotek Pharmaceutica...+0.25+3.88%
EGLTEgalet Corp+0.31+4.48%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts